Ansuman Chattopadhyay

Dr. Ansuman Chattopadhyay


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MRM K Ray
M K Ray
BDB Datta
B Datta
ACA Chakraborty
A Chakraborty
ACAnsuman Chattopadhyay
Ansuman Chattopadhyay
SMS Meza-Keuthen
S Meza-Keuthen
NGN K Gupta
N K Gupta
The eukaryotic initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) isolated from reticulocyte lysate protects the eIF-2 alpha subunit from eIF-2 kinase-catalyzed phosphorylation and promotes protein synthesis in the presence of active eIF-2 kinases. We have now studied the roles of p67 and eIF-2 kinases in regulation of protein synthesis using several animal cell lysates and an animal cell line (KRC-7) in culture under various growth conditions. The results are as follows. (i) Both p67 and eIF-2 kinase(s) are present in active forms in all animal cells under normal growth conditions and p67 protects the eIF-2 alpha subunit from eIF-2 kinase-catalyzed phosphorylation, thus promoting protein synthesis in the presence of active eIF-2 kinases. (ii) In heme-deficient reticulocyte lysates and in serum-starved KRC-7 cells in culture, p67 is deglycosylated and subsequently degraded. This leads to eIF-2 kinase-catalyzed eIF-2 alpha-subunit phosphorylation and thus to protein synthesis inhibition. (iii) Addition of a mitogen (namely, phorbol 12-myristate 13-acetate) to serum-starved KRC-7 cells in culture induces an increase of p67 and thus increases protein synthesis. These results suggest the following conclusions. (i) Protein synthesis inhibition in a heme-deficient reticulocyte lysate is not due to the activation of an eIF-2 kinase (heme-regulated inhibitor), as is generally believed, but is due to degradation of p67. The heme-regulated inhibitor is present in an active form and possibly in equal amounts in both heme-deficient and heme-supplemented reticulocyte lysates but cannot phosphorylate eIF-2 alpha subunit because of the presence of p67. (ii) p67 is essential for protein synthesis as it protects the eIF-2 alpha subunit from eIF-2 kinase-catalyzed phosphorylation and promotes protein synthesis in the presence of one or more active eIF-2 kinases present in all animal cells. (iii) p67 is both degradable and inducible. Only the p67 level correlates directly with the protein synthesis activity of the cell, indicating that p67 is a critical factor in protein synthesis regulation in animal cells.

18 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BMBrian Martin
Brian Martin
BGBeth Ann Gabris-Weber
Beth Ann Gabris-Weber
RRRajiv Reddy
Rajiv Reddy
GRGuillermo Romero
Guillermo Romero
ACAnsuman Chattopadhyay
Ansuman Chattopadhyay
GSGuy Salama
Guy Salama
‘Healthy’ aging drives structural and functional changes in the heart including maladaptive electrical remodeling, fibrosis and inflammation, which lower the threshold for cardiovascular diseases such as heart failure (HF) and atrial fibrillation (AF). Despite mixed results in recent clinical trials, Relaxin-therapy for 2-days could reduce mortality by 37% at 180-days post-treatment, in patients with acute decompensated HF. Relaxin’s short life-span (hours) but long-lasting protective actions led us to test the hypothesis that relaxin acts at a genomic level to reverse maladaptive remodeling in aging and HF. Young (9-month) and aged (24-month), male and female F-344/Brown Norway rats were treated with relaxin (0.4 mg/kg/day) for 2-weeks delivered by subcutaneous osmotic mini-pumps or with sodium acetate (controls). The genomic effects of aging and relaxin were evaluated by extracting RNA from the left ventricles and analyzing genomic changes by RNA-sequencing, Ingenuity Pathway Analysis, MetaCore and tissue immunohistochemistry. We found that aging promotes a native inflammatory response with distinct sex-differences and relaxin suppresses transcription of multiple genes and signaling pathways associated with inflammation and HF in both genders. In addition, aging significantly increased: macrophage infiltration and atrial natriuretic peptide levels in female ventricles, and activation of the complement cascade, whereas relaxin reversed these age-related effects. These data support the hypothesis that relaxin alters gene transcription and suppresses inflammatory pathways and genes associated with HF and aging. Relaxin’s suppression of inflammation and fibrosis supports its potential as a therapy for cardiovascular and inflammation-related diseases, such as HF, AF and diabetes.

1 August 2001 in Developmental Biology
Verified
Journal Article
Closed access
LMLisa M. Mehlmann
Lisa M. Mehlmann
ACAnsuman Chattopadhyay
Ansuman Chattopadhyay
GCGraham Carpenter
Graham Carpenter
LJLaurinda A. Jaffe
Laurinda A. Jaffe

1 April 2017 in Cytokine
Verified
Journal Article
Closed access
MSMichelle R. Simpson-Abelson
Michelle R. Simpson-Abelson
GHGerard Hernandez-Mir
Gerard Hernandez-Mir
ECErin E. Childs
Erin E. Childs
JCJ. Agustin Cruz
J. Agustin Cruz
APAmanda C. Poholek
Amanda C. Poholek
MMMandy J. McGeachy
Mandy J. McGeachy

1 July 2001 in Experimental Cell Research
Verified
Journal Article
Closed access
XWXue- Jie Wanga
Xue- Jie Wanga
HLHong- Jun Liaoa
Hong- Jun Liaoa
ACAnsuman Chattopadhyay
Ansuman Chattopadhyay
GCGraham Carpenter
Graham Carpenter

21 November 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KVKavita Vats
Kavita Vats
HTHua Tian
Hua Tian
KSKunal Singh
Kunal Singh
YTYulia Y. Tyurina
Yulia Y. Tyurina
LSLouis J. Sparvero
Louis J. Sparvero
YBYuri Bunimovich
Yuri Bunimovich
Dysregulations of epithelial-immune interactions frequently culminate in chronic inflammatory diseases of the skin, lungs, kidneys, and gastrointestinal tract. Yet, the intraepithelial processes that initiate and perpetuate inflammation in these organs are poorly understood. Here, by utilizing redox lipidomics we identified ferroptosis-associated peroxidation of polyunsaturated phosphatidylethanolamines in the epithelia of patients with asthma, cystic fibrosis, psoriasis, and renal failure. Focusing on psoriasis as a disease model, we used high-resolution mass spectrometry imaging and identified keratin 14–expressing (K14-expressing) keratinocytes executing a ferroptotic death program in human psoriatic skin. Psoriatic phenotype with characteristic Th1/Th17 skin and extracutaneous immune responses was initiated and maintained in a murine model designed to actuate ferroptosis in a fraction of K14 + glutathione peroxidase 4–deficient (Gpx4-deficient) epidermal keratinocytes. Importantly, an antiferroptotic agent, liproxstatin-1, was as effective as clinically relevant biological IL-12/IL-23/TNF-α–targeting therapies or the depletion of T cells in completely abrogating molecular, biochemical, and morphological features of psoriasis. As ferroptosis in select epidermal keratinocytes triggers and sustains a pathological psoriatic multiorgan inflammatory circuit, we suggest that strategies targeting ferroptosis or its causes may be effective in preventing or ameliorating a variety of chronic inflammatory diseases.